-----BEGIN PRIVACY-ENHANCED MESSAGE----- Proc-Type: 2001,MIC-CLEAR Originator-Name: webmaster@www.sec.gov Originator-Key-Asymmetric: MFgwCgYEVQgBAQICAf8DSgAwRwJAW2sNKK9AVtBzYZmr6aGjlWyK3XmZv3dTINen TWSM7vrzLADbmYQaionwg5sDW3P6oaM5D3tdezXMm7z1T+B+twIDAQAB MIC-Info: RSA-MD5,RSA, NBeJGRTnO/z1BIU21//Mp7Nxj2yFcIKm3TfIRFDrgokCS+cuTmfsmr8UwdcwEoca 61nv+ALa9wOxH8Uo3XUf3g== 0001225208-09-001329.txt : 20090112 0001225208-09-001329.hdr.sgml : 20090112 20090112164017 ACCESSION NUMBER: 0001225208-09-001329 CONFORMED SUBMISSION TYPE: 4 PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 20090108 FILED AS OF DATE: 20090112 DATE AS OF CHANGE: 20090112 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: ABELE JOHN E CENTRAL INDEX KEY: 0000901430 FILING VALUES: FORM TYPE: 4 SEC ACT: 1934 Act SEC FILE NUMBER: 001-11083 FILM NUMBER: 09522057 BUSINESS ADDRESS: STREET 1: C/O BOSTON SCIENTIFIC CORP STREET 2: 480 PLEASANT ST CITY: WATERTOWN STATE: MA ZIP: 02172 MAIL ADDRESS: STREET 1: C/O BOSTON SCIENTIFIC CORP STREET 2: ONE BOSTON SCIENTIFIC PL CITY: NATICK STATE: MA ZIP: 01760-1537 ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: BOSTON SCIENTIFIC CORP CENTRAL INDEX KEY: 0000885725 STANDARD INDUSTRIAL CLASSIFICATION: SURGICAL & MEDICAL INSTRUMENTS & APPARATUS [3841] IRS NUMBER: 042695240 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 BUSINESS ADDRESS: STREET 1: ONE BOSTON SCIENTIFIC PL CITY: NATICK STATE: MA ZIP: 01760-1537 BUSINESS PHONE: 5086508000 4 1 doc4.xml X0303 4 2009-01-08 0000885725 BOSTON SCIENTIFIC CORP BSX 0000901430 ABELE JOHN E ONE BOSTON SCIENTIFIC PLACE NATICK MA 01760-1537 1 Common Stock 2009-01-08 4 S 0 100000 7.681 D 32183029 D Common Stock 2009-01-09 4 S 0 100000 7.715 D 32083029 D Common Stock 400000 I By Spouse Common Stock 351098 I By Trust Forward Sale Contract 0 2009-01-09 4 J 0 119722 0 A 2010-01-08 2010-01-08 Common Stock 119722 119722 D The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on November 28, 2008. The weighted average sales price is reported as stock sales were aggregated for reporting purposes. The per share transaction price ranged from $7.81 to $7.53. The reporting person will provide, upon request from an appropriate party, the per share sales volumes and prices. The weighted average sales price is reported as stock sales were aggregated for reporting purposes. The per share transaction price ranged from $7.95 to $7.64. The reporting person will provide, upon request from an appropriate party, the per share sales volumes and prices. Common stock held by the reporting person's wife. The reporting person disclaims beneficial ownership of these shares. Common stock held by trust for the benefit of the reporting person's child of which the reporting person is a trustee. The reporting person disclaims beneficial ownership of these shares. On November 28, 2008, the reporting person entered into a Rule 10b5-1 trading plan with an unaffiliated commercial bank to execute a series of variable prepaid forward sale contracts. Under the contract reported on this form, the reporting person will deliver to the bank up to 119,722 shares of the Issuer's common stock depending on market prices at maturity on January 8, 2010. If the market price per share at maturity is equal to or less than the floor price of $7.71 per share, the reporting person will deliver 119,722 shares to the bank. If the market price per share at maturity is greater than the floor price, the reporting person will deliver a fewer number of shares. In exchange, the bank is obligated to pay $764,627.92 to the reporting person three business days after the date of the contract. At the option of the reporting person, the contract may be settled at maturity by delivering cash in lieu of stock. The reporting person pledged 119,722 shares of the Issuer's common stock to secure its obligations under the contract and retains dividends and voting rights in the shares during the term of the pledge. /s/ Lawrence J. Knopf, Attorney-in-fact 2009-01-12 -----END PRIVACY-ENHANCED MESSAGE-----